Comparison

Brivanib (alaninate) European Partner

Item no. TMO-T2576-25mg
Manufacturer TargetMol
CASRN 649735-63-7
Amount 25 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,98
Smiles C[C@H](COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C)OC(=O)[C@H](C)N
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Brivanib Alaninate,BMS-582664
Similar products 649735-63-7
Shipping Condition Cool pack
Available
Manufacturer - Targets
VEGFR|||FGFR|||Autophagy
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
441.46
Description
Brivanib Alaninate (BMS-582664) is the alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression.
Pathways
Angiogenesis|||Tyrosine Kinase/Adaptors|||Autophagy

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close